Correlation Between VanEck Pharmaceutical and VanEck Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VanEck Pharmaceutical and VanEck Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VanEck Pharmaceutical and VanEck Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VanEck Pharmaceutical ETF and VanEck Biotech ETF, you can compare the effects of market volatilities on VanEck Pharmaceutical and VanEck Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VanEck Pharmaceutical with a short position of VanEck Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of VanEck Pharmaceutical and VanEck Biotech.

Diversification Opportunities for VanEck Pharmaceutical and VanEck Biotech

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between VanEck and VanEck is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding VanEck Pharmaceutical ETF and VanEck Biotech ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VanEck Biotech ETF and VanEck Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VanEck Pharmaceutical ETF are associated (or correlated) with VanEck Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VanEck Biotech ETF has no effect on the direction of VanEck Pharmaceutical i.e., VanEck Pharmaceutical and VanEck Biotech go up and down completely randomly.

Pair Corralation between VanEck Pharmaceutical and VanEck Biotech

Considering the 90-day investment horizon VanEck Pharmaceutical ETF is expected to generate 0.61 times more return on investment than VanEck Biotech. However, VanEck Pharmaceutical ETF is 1.64 times less risky than VanEck Biotech. It trades about -0.2 of its potential returns per unit of risk. VanEck Biotech ETF is currently generating about -0.12 per unit of risk. If you would invest  9,214  in VanEck Pharmaceutical ETF on August 26, 2024 and sell it today you would lose (356.00) from holding VanEck Pharmaceutical ETF or give up 3.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

VanEck Pharmaceutical ETF  vs.  VanEck Biotech ETF

 Performance 
       Timeline  
VanEck Pharmaceutical ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Pharmaceutical ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.
VanEck Biotech ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Biotech ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's fundamental drivers remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.

VanEck Pharmaceutical and VanEck Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VanEck Pharmaceutical and VanEck Biotech

The main advantage of trading using opposite VanEck Pharmaceutical and VanEck Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VanEck Pharmaceutical position performs unexpectedly, VanEck Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Biotech will offset losses from the drop in VanEck Biotech's long position.
The idea behind VanEck Pharmaceutical ETF and VanEck Biotech ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
CEOs Directory
Screen CEOs from public companies around the world